Dupilumab: observed
90 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- ADBest TREAT RegistryRecruitingNCT07904546Report a problem
- T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPDRecruitingNCT07823842Report a problem
- Neural Dissimilarity in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With BiologicsNot yet recruitingNCT07819162Report a problem
- The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) RegistryRecruitingNCT07612878Report a problem
- Blood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Prognosis of Severe Eosinophilic ACOS With BiologicsNot yet recruitingNCT07602881Report a problem
- The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic DermatitisRecruitingNCT07467564Report a problem
- Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa RicaNot yet recruitingNCT07448363Report a problem
- A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria PatientsRecruitingNCT07408219Report a problem
- Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported OutcomesRecruitingNCT07380711Report a problem
- Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo NodularisRecruitingNCT07276425Report a problem
- Dupilumab Therapy for EGIDsRecruitingNCT07257835Report a problem
- Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world ConditionsRecruitingNCT07052396Report a problem
- DETACT sEvere asThmAtiC paTients - a Pilot StudyRecruitingNCT07025200Report a problem
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495Report a problem
- Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II InflammationRecruitingNCT07012928Report a problem
- Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.RecruitingNCT06892704Report a problem
- The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world StudyEnrolling by invitationNCT06851403Report a problem
- A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in GermanyRecruitingNCT06695897Report a problem
- Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)RecruitingNCT06683261Report a problem
- Expanded Access of Dupilumab in Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Previously Treated With LinvoseltamabAvailableNCT06631677Report a problem
- BIOlogics in Severe Nasal POlyposis SurvEy.: a French RegistryRecruitingNCT06501807Not applicableReport a problem
- Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNPRecruitingNCT06398873Report a problem
- Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive ModelsRecruitingNCT06366932Phase 4Report a problem
- Immunological Mechanisms Underlying Mucosal IgE ResponsesRecruitingNCT06234761Report a problem
- A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab TreatmentRecruitingNCT06192563Report a problem
- Registry for Systemic Eczema TreatmentsRecruitingNCT06136767Report a problem
- Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With BiotherapyRecruitingNCT05972213Report a problem
- Real Life Study of Biologicals in Patients With Severe CRSwNPRecruitingNCT05938972Report a problem
- Mind and Skin - the Neurocutaneous Axis in Atopic EczemaRecruitingNCT05790330Report a problem
- Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous SecretionRecruitingNCT05787678Report a problem
- Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis TherapyRecruitingNCT05674695Report a problem
- Microbiome in Atopic Dermatitis Under Systemic TherapyRecruitingNCT05099315Report a problem
- The Nasal Microbiome and Its Importance in DiseaseRecruitingNCT05061329Report a problem
- Compassionate Use or Expanded Access of DupilumabAvailableNCT04776694Report a problem
- Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentRecruitingNCT04276623Report a problem
- BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic DermatitisRecruitingNCT03549416Report a problem
- Molecular Signatures in Inflammatory Skin DiseaseRecruitingNCT03358693Report a problem
- Dupilumab in Type 2-Inflamed COPD Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort StudyCompletedNCT07788092Report a problem
- Multi-omics in Severe Asthma From Olive Pollen AllergyActive, not recruitingNCT07721376Report a problem
- Use of Dupilumab in Asthma in Real-world SettingActive, not recruitingNCT07637292Report a problem
- Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsCompletedNCT07574294Report a problem
- A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous UrticariaTerminatedNCT07316114Report a problem
- Successful Treatment of Netherton Syndrome With Combination of Secukinumab and DupilumabCompletedNCT07151508Report a problem
- The Role of Confocal Microscopy in Estimating Dupilumab Treatment Response for Moderate/Severe Atopic DermatitisCompletedNCT07098000Report a problem
- Long-term Effect of Dupilumab in N-ERDCompletedNCT07049978Report a problem
- Replication of the Heads Up Atopic Dermatitis Trial With Registry DataTerminatedNCT06937788Report a problem
- A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareActive, not recruitingNCT06693531Report a problem
- International Severe CRSwNP Registry 2024-2028Active, not recruitingNCT06617754Report a problem
- Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in SpainActive, not recruitingNCT06415175Report a problem
- Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in FranceActive, not recruitingNCT06393946Report a problem
- A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health ServiceCompletedNCT06261567Report a problem
- A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving DupilumabActive, not recruitingNCT06169527Report a problem
- Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic DermatitisCompletedNCT06099704Report a problem
- A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical RoutineActive, not recruitingNCT06087627Report a problem
- An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe AsthmaCompletedNCT06064526Report a problem
- Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic DermatitisActive, not recruitingNCT06039241Report a problem
- A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world SettingCompletedNCT06018441Report a problem
- Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite Appropriate Medical and Surgical Treatment.TerminatedNCT06017427Report a problem
- Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational StudyCompletedNCT05991323Report a problem
- Compassionate Use of Dupilumab for Adult Patients With Bullous PemphigoidApproved for marketingNCT05906706Report a problem
- Viral and Epigenetic Influences in CRSwNPActive, not recruitingNCT05857228Report a problem
- Efficacy and Safety of Dupilumab in Patients With Bullous PemphigoidCompletedNCT05649579Report a problem
- Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)Status unknownNCT05529784Report a problem
- A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech RepublicCompletedNCT05527964Report a problem
- IL13 Signaling in Allergic AsthmaCompletedNCT05478824Report a problem
- A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanCompletedNCT05442645Report a problem
- Real Life Experience Survey of Dupilumab in the NetherlandsCompletedNCT05331755Report a problem
- Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of TherapyCompletedNCT05270278Report a problem
- Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal PolyposisActive, not recruitingNCT05246267Report a problem
- BIOlogics in Severe Nasal POlyposis SurvEyActive, not recruitingNCT05228041Report a problem
- A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf CountriesCompletedNCT05214326Report a problem
- Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT05203380Report a problem
- Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune ModulationCompletedNCT05098821Report a problem
- Results in Real Clinical Practice of Treatment of Moderate-severe Atopic DermatitisStatus unknownNCT05078294Report a problem
- A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)CompletedNCT05070663Report a problem
- Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)Active, not recruitingNCT04959448Report a problem
- Similarities and Differences of Biological Therapies for Severe Asthma.Status unknownNCT04665141Report a problem
- Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)CompletedNCT04550962Report a problem
- Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04462055Report a problem
- Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant TherapyStatus unknownNCT04324866Report a problem
- Registry of Asthma Patients Initiating DUPIXENT®CompletedNCT04287621Report a problem
- Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic DermatitisCompletedNCT04287608Report a problem
- Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected PregnancyCompletedNCT04173442Report a problem
- Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With DupilumabStatus unknownNCT04066998Not applicableReport a problem
- Dupilumab for Severe Asthma in a Real Life SettingCompletedNCT04022447Report a problem
- Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)Active, not recruitingNCT03992417Report a problem
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)CompletedNCT03936335Report a problem
- Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)Active, not recruitingNCT03428646Report a problem
- Dupilumab Phase 4 StudyTerminatedNCT03411837Report a problem
- Dupilumab Compassionate Use StudyApproved for marketingNCT03020810Report a problem